Latest Regulation News

Little Green Pharma Ltd reported a 9.6% revenue increase to $19.2 million and slashed its net loss by 73% in the half-year ending September 2025, driven by strong growth in European medicinal cannabis markets.

Revolver Resources has upgraded its Dianne Copper Deposit resource with a 140% increase in Indicated material and a 26% rise in copper grade, setting the stage for a targeted mining restart in 2026.

Kore Potash has raised approximately US$12.2 million through a new share issue to fund critical project payments and maintain working capital for the next year. The fundraise also opens the door for major shareholders to increase their stakes, pending approvals.

Cuscal Limited has received final regulatory approval from APRA for its full acquisition of Indue Limited, setting the stage for completion by early December.

Monash IVF Group reported solid FY25 revenue and EBITDA growth despite sector softness and clinical incidents, while announcing a leadership transition and dividend pause.

LaserBond’s 2025 AGM reveals a pivotal CEO transition alongside a strong financial rebound driven by strategic investments and technology licensing deals.

Stealth Group Holdings has explained the late filing of a director’s interest notice as an administrative oversight, assuring no market harm occurred. The company has since strengthened its compliance controls to prevent future lapses.

AXP Energy reports sustained strong flowback at its Charlie #1 well in Oklahoma, moving swiftly to install infrastructure for natural gas sales and early revenue generation.

Group One Capital Limited has adopted a comprehensive replacement Constitution at its 2025 Annual General Meeting, setting a refreshed governance framework aligned with current regulatory standards.

Dataworks Limited solidifies its leadership in regulated gaming technology with its Centralised Self-Exclusion platform, backed by major government contracts and a robust growth pipeline.

5E Advanced Materials has announced a significant upgrade to its Fort Cady Project’s mineral resources, increasing measured and indicated boric acid resources by 61% and lithium carbonate equivalent by 54%, reinforcing its position as a key domestic supplier of critical minerals.

Bio-Gene Technology reports significant progress in developing its bio-insecticides Flavocide and Qcide, including new efficacy data and organic certification, positioning the company for growth amid rising global demand for safer pest control.